Protective effects of exercise and phosphoinositide 3-kinase(p110α) signaling in dilated and hypertrophic cardiomyopathy

被引:253
|
作者
McMullen, Julie R. [1 ]
Amirahmadi, Fatemeh
Woodcock, Elizabeth A.
Schinke-Braun, Martina
Bouwman, Russell D.
Hewitt, Kimberly A.
Mollica, Janelle P.
Zhang, Li
Zhang, Yunyu
Shioi, Tetsuo
Buerger, Antje
Izumo, Seigo
Jay, Patrick Y.
Jennings, Garry L.
机构
[1] Baker Heart Res Inst, Expt Cardiol & Heart Failure Div, Melbourne, Vic 8008, Australia
[2] Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA
[3] Novartis Inst Biomed Res, Cambridge, MA 02139 USA
[4] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA
关键词
heart failure; signal transduction; heart growth; athlete's heart;
D O I
10.1073/pnas.0606663104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Physical activity protects against cardiovascular disease, and physiological cardiac hypertrophy associated with regular exercise is usually beneficial, in marked contrast to pathological hypertrophy associated with disease. The p110 alpha isoform of phosphoinositide 3-kinase (PI3K) plays a critical role in the induction of exercise-induced hypertrophy. Whether it or other genes activated in the athlete's heart might have an impact on cardiac function and survival in a setting of heart failure is unknown. To examine whether progressive exercise training and PI3K(p110 alpha) activity affect survival and/or cardiac function in two models of heart disease, we subjected a transgenic mouse model of dilated cardiomyopathy (DCM) to swim training, genetically crossed cardiac-specific transgenic mice with increased or decreased PI3K(p110 alpha) activity to the DCM model, and subjected PI3K(p110 alpha) transgenics to acute pressure overload (ascending aortic constriction). Life span, cardiac function, and molecular markers of pathological hypertrophy were examined. Exercise training and increased cardiac PI3K(p110 alpha) activity prolonged survival in the DCM model by 15-20%. In contrast, reduced PI3K(p110 alpha) activity drastically shortened lifespan by approximate to 50%. Increased PI3K(p110 alpha) activity had a favorable effect on cardiac function and fibrosis in the pressure-overload model and attenuated pathological growth. PI3K(p110 alpha) signaling negatively regulated G protein-coupled receptor stimulated extracellular responsive kinase and Akt (via PI3K, p110 gamma) activation in isolated cardiomyocytes. These findings suggest that exercise and enhanced PI3K(p110 alpha) activity delay or prevent progression of heart disease, and that supraphysiologic activity can be beneficial. Identification of genes important for hypertrophy in the athlete's heart could offer new strategies for treating heart failure.
引用
收藏
页码:612 / 617
页数:6
相关论文
共 50 条
  • [1] The protective effects of exercise and phosphoinositide 3-kinase (p110α) in the failing heart
    Owen, Kate L.
    Pretorius, Lynette
    McMullen, Julie R.
    CLINICAL SCIENCE, 2009, 116 (5-6) : 365 - 375
  • [2] Phosphoinositide 3-Kinase p110α Gene Therapy Ameliorates Diabetic Cardiomyopathy in Mice
    Prakoso, Darnel
    De Blasio, Miles J.
    Qin, Chengxue
    Rosli, Sarah
    Kiriazis, Helen
    Qian, Hongwei
    Du, Xiao-Jun
    Weeks, Kate L.
    Gregorevic, Paul
    McMullen, Julie R.
    Ritchie, Rebecca H.
    CIRCULATION, 2016, 134
  • [3] Human platelets contain p110δ phosphoinositide 3-kinase
    Zhang, J
    Vanhaesebroeck, B
    Rittenhouse, SE
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 296 (01) : 178 - 181
  • [4] p110 delta, a novel phosphoinositide 3-kinase in leukocytes
    Vanhaesebroeck, B
    Welham, MJ
    Kotani, K
    Stein, R
    Warne, PH
    Zvelebil, MJ
    Higashi, K
    Volinia, S
    Downward, J
    Waterfield, MD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) : 4330 - 4335
  • [5] Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation
    Yamaguchi, Hideki
    Fukami, Kiyoko
    Sakai, Ryuichi
    CANCER RESEARCH, 2011, 71
  • [6] Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation
    Yamaguchi, Hideki
    Yoshida, Shuhei
    Muroi, Emi
    Yoshida, Nachi
    Kawamura, Masahiro
    Kouchi, Zen
    Nakamura, Yoshikazu
    Sakai, Ryuichi
    Fukami, Kiyoko
    JOURNAL OF CELL BIOLOGY, 2011, 193 (07): : 1275 - 1288
  • [7] P110 delta, a novel human phosphoinositide 3-kinase
    Vanhaesebroeck, B
    Kotani, K
    Stein, RC
    Volinia, S
    Downward, J
    Waterfield, MD
    FASEB JOURNAL, 1996, 10 (06): : 2280 - 2280
  • [8] Eosinophilic esophagitis in patients with Phosphoinositide 3-Kinase p110δ
    Lawson, Jamie
    Uzel, Gulbu
    Webster, Sharon
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (SUPPL 1) : S154 - S154
  • [9] p110γ and p110δ phosphoinositide 3-kinase signaling pathways synergize to control development and functions of murine NK cells
    Tassi, Ilaria
    Cella, Marina
    Gilfillan, Susan
    Turnbull, Isaiah
    Diacovo, Thomas G.
    Penninger, Josef M.
    Colonna, Marco
    IMMUNITY, 2007, 27 (02) : 214 - 227
  • [10] Effects of oncogenic p110α subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase
    Carson, Jeffrey D.
    Van Aller, Glenn
    Lehr, Ruth
    Sinnamon, Robert H.
    Kirkpatrick, Robert B.
    Auger, Kurt R.
    Dhanak, Dashyant
    Copeland, Robert A.
    Gontarek, Richard R.
    Tummino, Peter J.
    Luo, Lusong
    BIOCHEMICAL JOURNAL, 2008, 409 (519-524) : 519 - 524